Literature DB >> 21723111

The effects of variations in the density and composition of eye materials on ophthalmic brachytherapy dosimetry.

Somayeh Asadi1, Seyed Farhad Masoudi, Majid Shahriari.   

Abstract

In ophthalmic brachytherapy dosimetry, it is common to consider the water phantom as human eye anatomy. However, for better clinical analysis, there is a need for the dose determination in different parts of the eye. In this work, a full human eye is simulated with MCNP-4C code by considering all parts of the eye, i.e., the lens, cornea, retina, choroid, sclera, anterior chamber, optic nerve, and bulk of the eye comprising vitreous body and tumor. The average dose in different parts of this full model of the human eye is determined and the results are compared with the dose calculated in water phantom. The central axes depth dose and the dose in whole of the tumor for these 2 simulated eye models are calculated as well, and the results are compared. Copyright Â
© 2012 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21723111     DOI: 10.1016/j.meddos.2010.12.003

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  3 in total

1.  Dosimetric comparison between realistic ocular model and other models for COMS plaque brachytherapy with 103Pd, 131Cs, and 125I radioisotopes.

Authors:  Atiyeh Ebrahimi-Khankook; Alireza Vejdani-Noghreiyan
Journal:  Radiat Environ Biophys       Date:  2018-06-07       Impact factor: 1.925

2.  Effects of defining realistic compositions of the ocular melanoma on proton therapy.

Authors:  Sh Keshazare; S F Masoudi; F S Rasouli
Journal:  J Biomed Phys Eng       Date:  2014-12-15

3.  Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.

Authors:  Somayeh Asadi; Mehdi Vaez-zadeh; S Farhad Masoudi; Faezeh Rahmani; Courtney Knaup; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.